Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
RTX Corp
RTX
|
$606M |
| 2 |
Amazon
AMZN
|
$597M |
| 3 |
Meta Platforms (Facebook)
META
|
$497M |
| 4 |
Edwards Lifesciences
EW
|
$464M |
| 5 |
Otis Worldwide
OTIS
|
$377M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$878M |
| 2 |
RTN
Raytheon Company
RTN
|
$537M |
| 3 |
Apple
AAPL
|
$457M |
| 4 |
Bristol-Myers Squibb
BMY
|
$427M |
| 5 |
Accenture
ACN
|
$245M |
Sector Composition
| 1 | Technology | 23.73% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Exxon Mobil
XOM
$487B
| $2.84B | 0.61% | 63,592,947 +730,138 | +1% | +$32.6M |
|
27
AbbVie
ABBV
$371B
| $2.84B | 0.61% | 28,958,592 +3,185,087 | +12% | +$312M |
|
28
PepsiCo
PEP
$203B
| $2.78B | 0.59% | 21,045,591 +401,410 | +2% | +$53M |
|
29
Comcast
CMCSA
$125B
| $2.77B | 0.59% | 71,145,936 +2,008,533 | +3% | +$78.2M |
|
30
Bank of America
BAC
$375B
| $2.73B | 0.58% | 114,962,776 -1,672,404 | -1% | -$39.6M |
|
31
Walmart
WMT
$769B
| $2.55B | 0.55% | 21,322,670 +135,933 | +0.6% | +$16.3M |
|
32
Chevron
CVX
$324B
| $2.5B | 0.54% | 28,093,217 -102,473 | -0.4% | -$9.13M |
|
33
Coca-Cola
KO
$296B
| $2.48B | 0.53% | 55,523,910 +1,411,597 | +3% | +$63M |
|
34
Amgen
AMGN
$155B
| $2.36B | 0.51% | 10,029,477 -87,724 | -0.9% | -$20.7M |
|
35
Salesforce
CRM
$242B
| $2.36B | 0.5% | 12,601,645 +510,294 | +4% | +$95.4M |
|
36
Abbott
ABT
$230B
| $2.3B | 0.49% | 25,238,694 +391,238 | +2% | +$35.7M |
|
37
McDonald's
MCD
$223B
| $2.07B | 0.44% | 11,237,712 +12,559 | +0.1% | +$2.31M |
|
38
Eli Lilly
LLY
$658B
| $2.07B | 0.44% | 12,612,063 -35,594 | -0.3% | -$5.83M |
|
|
39
Accenture
ACN
$161B
| $2.02B | 0.43% | 9,421,039 -1,142,308 | -11% | -$245M |
|
40
Thermo Fisher Scientific
TMO
$186B
| $2B | 0.43% | 5,535,685 +76,104 | +1% | +$27.5M |
|
41
Costco
COST
$418B
| $2B | 0.43% | 6,592,733 +172,019 | +3% | +$52.1M |
|
42
Texas Instruments
TXN
$184B
| $1.96B | 0.42% | 15,486,203 -268,408 | -2% | -$34M |
|
|
43
Bristol-Myers Squibb
BMY
$95.8B
| $1.93B | 0.41% | 32,957,360 -7,276,641 | -18% | -$427M |
|
44
Nike
NKE
$115B
| $1.88B | 0.4% | 19,247,004 -1,860,268 | -9% | -$182M |
|
45
Medtronic
MDT
$119B
| $1.87B | 0.4% | 20,425,066 +97,941 | +0.5% | +$8.97M |
|
46
Broadcom
AVGO
$1.39T
| $1.84B | 0.39% | 5,835,013 +136,103 | +2% | +$42.9M |
|
47
Philip Morris
PM
$259B
| $1.81B | 0.39% | 25,831,414 -980,745 | -4% | -$68.6M |
|
48
American Tower
AMT
$94.7B
| $1.71B | 0.37% | 6,623,650 +399,248 | +6% | +$103M |
|
49
NextEra Energy, Inc.
NEE
$149B
| $1.69B | 0.36% | 7,036,713 -204,174 | -3% | -$49M |
|
50
Oracle
ORCL
$632B
| $1.68B | 0.36% | 30,482,373 -443,732 | -1% | -$24.5M |
|